AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Identify the ideal low-cost index funds for retirement using transparent criteria and performance benchmarks to guide your choices.
27,037 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Investors await Intuitive Surgical’s Q2 release after a sharp YTD decline. Live updates will track da Vinci growth, u...
Pi Network's PI token surged 16% intraday, reaching a three-month high as the project unveiled distributed AI computi...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
OpenAI is steering its ChatGPT platform toward a single, all-encompassing AI assistant as it readies for a potential ...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
As Walmart names John Furner CEO, the retail giant leans on AI and a family-led leadership creed to reshape operation...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
As market volatility sinks into a familiar pattern, insiders are quietly loading up on beaten-down stock wall street ...
Vet clinics are raising fees as fewer pet visits occur, turning pet ownership into a costlier proposition. The trend ...
Netflix remains the benchmark in streaming, but rivals are accelerating with new pricing, ad tiers, and AI-driven fea...
A leading US bitcoin ATM operator filed for Chapter 11 in May, setting off a broader wave of scrutiny, bankrupted fir...